NIH
-
Wilms’ tumors differ in developing nations
In addition to limited health care resources, biological factors may play a role in the poor survival of children with a common kidney cancer in developing nations. Read MoreApril 13, 2012
-
Targeting post-transplant diabetes
Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes. Read MoreApril 12, 2012
-
New tool hooks heart failure drugs
A new screening tool – using glowing fish embryos – could identify therapeutics for myocardial hypertrophy and heart failure. Read MoreApril 6, 2012
-
Plant compound quells inflammation
Berberine, an herbal remedy for diarrhea and intestinal parasites, may be an effective treatment for gastrointestinal inflammatory diseases. Read MoreApril 6, 2012
-
Stem cell population may hold colon cancer clues
Vanderbilt-Ingram Cancer Center researchers have identified a new population of intestinal stem cells that may hold clues to the origin of colorectal cancer. Read MoreMarch 29, 2012
-
Smoking stokes cells’ cancer capacity
Cellular pathways altered by chronic exposure to cigarette smoke may reveal new biomarkers to assess smoking-induced lung cancer risk. Read MoreMarch 23, 2012
-
Obesity turns “good” cholesterol bad
Studies offer new insights into how obesity impairs the function of HDL, the “good” cholesterol. Read MoreMarch 21, 2012
-
Mouse model for autism yields clues to a 50-year-old mystery
A genetic variation that causes early disruptions in serotonin signaling in the brain may contribute to autism spectrum disorder and other enduring effects on behavior. Read MoreMarch 20, 2012
-
iPOND method goes fishing for proteins
A new tool will allow researchers to identify proteins involved in DNA replication and damage repair, processes that go awry in cancer. Read MoreMarch 19, 2012
-
Colon cancer’s cellular crossroads
New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease. Read MoreMarch 16, 2012